Grail Inc (GRAL)

Currency in USD
75.70
+0.86(+1.15%)
Real-time Data·

GRAL Earnings

Latest Release
Aug 05, 2026
EPS / Forecast
-2.56 / --
Revenue / Forecast
44.7M / 43.2M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2026-2.56/--44.70M/43.20M--+3.47%Free Sign Up
03/2026-2.29/--40.80M/40.40M--+0.99%Free Sign Up
12/2025-2.44/-4.0143.60M/--+39.15%--Free Sign Up
09/2025-2.46/-3.9936.19M/--+38.35%--Free Sign Up
06/2025-3.18/-4.1235.54M/--+22.82%--Free Sign Up
03/2025-3.10/-4.2631.84M/--+27.23%--Free Sign Up
12/2024-2.89/--38.25M/------Free Sign Up
09/2024-3.94/--28.65M/------Free Sign Up
06/2024-51.05/--31.99M/------Free Sign Up

All numbers in USD

Grail Inc Earnings Call Summary for Q2/2026

  • GRAIL Q2 revenue hit $44.7M, beating estimates by 3.5% with 26% YoY growth; test volume surged 35% to 61,000 tests driven by screening sales.
  • Shares dropped 8.33% after-hours despite revenue beat as adjusted EBITDA loss widened to $90.3M from $78.4M YoY; net loss remained $110.2M.
  • Company expects FDA advisory committee meeting fall 2026 with potential approval in early 2027, viewed as critical catalyst for payer coverage.
  • Cash position stands at $861.6M including $110M Samsung investment; Illumina 7% royalty resumes Q4 2026, potentially impacting 2027 margins.
  • Management expanded sales force ahead of FDA decision; average test price fell to ~$700 due to strategic mix shift toward digital health partnerships.
Last Updated: 08/06/2026, 05:32 AM
Read Full Transcript

FAQ

What Is Grail's Earnings Per Share (TTM)?

The Grail EPS (TTM) is -9.75.

When Is The Next Grail Earnings Date?

Grail will release its next earnings report on Aug 05, 2026.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.